➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

AstraZeneca
Express Scripts
Moodys
Mallinckrodt
Colorcon
Medtronic

Last Updated: October 18, 2021

DrugPatentWatch Database Preview

Patent: 6,410,238

➤ Get the DrugPatentWatch Daily Briefing

« Back to Dashboard

Summary for Patent: 6,410,238
Title: Box-dependent Myc-interacting protein (Bin1) compositions and uses thereof
Abstract:The present invention provides Bin1 genomic sequences and proteins encoded thereby. Also provided are compositions and methods utilizing these sequences and proteins in the diagnosis and treatment of cancers and hyperplastic disease states. Further provided are oligonucleotides derived from sequences encoding Bin1, as well as compositions and methods utilizing same for diagnostic and therapeutic purposes.
Inventor(s): Prendergast; George C. (Bala Cynwyd, PA), Sakamuro; Daitoku (West Lafayette, IN)
Assignee: The Wistar Institute of Anatomy and Biology (Philadelphia, PA)
Application Number:09/445,247
Patent Claims:see list of patent claims

Details for Patent 6,410,238

Applicant Tradename Biologic Ingredient Dosage Form BLA Approval Date Patent No. Assignee Estimated Patent Expiration Status Orphan Source
Schering INTRON A interferon alfa-2b VIAL 103132 1986-06-04 ⤷  Free Forever Trial The Wistar Institute of Anatomy and Biology (Philadelphia, PA) 2017-06-06 RX search
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Approval Date >Patent No. >Assignee >Estimated Patent Expiration >Status >Orphan >Source

International Patent Family for US Patent 6,410,238

Country Patent Number Estimated Expiration
World Intellectual Property Organization (WIPO) 9634627 ⤷  Free Forever Trial
World Intellectual Property Organization (WIPO) 9855151 ⤷  Free Forever Trial
United States of America 2003166021 ⤷  Free Forever Trial
United States of America 5605830 ⤷  Free Forever Trial
United States of America 5723581 ⤷  Free Forever Trial
United States of America 6048702 ⤷  Free Forever Trial
European Patent Office 0828512 ⤷  Free Forever Trial
>Country >Patent Number >Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School
McKinsey
Boehringer Ingelheim
McKesson
Johnson and Johnson
Mallinckrodt

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.